Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pilar Tamayo

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Acta Tropica|December 26, 2021
Usefulness of the FDG PET/CT in the management of cystic echinococcosis: A pilot studyFernando Salvador, Laura Escolà-Vergé, Marta Barios, et al.
Cancers|February 23, 2020
Biological Features and Prognostic Impact of Bone Marrow Infiltration in Patients with Diffuse Large B-Cell LymphomaSara Alonso-Álvarez, Miguel Alcoceba, María García-Álvarez, et al.
British Journal of Haematology|July 27, 2021
Liquid biopsy: a non-invasive approach for Hodgkin lymphoma genotypingMiguel Alcoceba, María García-Álvarez, M Carmen Chillón, et al.
Blood Cancer Journal|June 19, 2019
Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomasMaría García-Álvarez, Sara Alonso-Álvarez, Isabel Prieto-Conde, et al.
British Journal of Haematology|May 29, 2024
Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual diseaseMiguel Alcoceba, James P Stewart, María García-Álvarez, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 21, 2023
[<sup>18</sup>F]DCFPyL PET/CT versus [<sup>18</sup>F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative studyDaniela-Elena Oprea-Lager, Eric Gontier, Lina García-Cañamaque, et al.
Cancers|January 8, 2025
The Value of Bone Marrow Assessment by FDG PET/CT, Biopsy and Aspirate in the Upfront Evaluation of Mantle Cell Lymphoma: A Nationwide Cohort StudyIsabel Ródenas Quiñonero, Javier Marco-Ayala, Tzu-Hua Chen-Liang, et al.
Blood Advances|November 27, 2024
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myelomaInés Zugasti, Marta Tormo-Ratera, Aina Oliver-Caldés, et al.
Cancer Medicine|November 14, 2022
Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort studyIsabel Ródenas-Quiñonero, Tzu Chen-Liang, Taida Martín-Santos, et al.
Cancer Medicine|September 30, 2017
Bone marrow biopsy superiority over PET/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphomaTzu-Hua Chen-Liang, Taida Martín-Santos, Andrés Jerez, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Acta Tropica|December 26, 2021
Usefulness of the FDG PET/CT in the management of cystic echinococcosis: A pilot studyFernando Salvador, Laura Escolà-Vergé, Marta Barios, et al.
Cancers|February 23, 2020
Biological Features and Prognostic Impact of Bone Marrow Infiltration in Patients with Diffuse Large B-Cell LymphomaSara Alonso-Álvarez, Miguel Alcoceba, María García-Álvarez, et al.
British Journal of Haematology|July 27, 2021
Liquid biopsy: a non-invasive approach for Hodgkin lymphoma genotypingMiguel Alcoceba, María García-Álvarez, M Carmen Chillón, et al.
Blood Cancer Journal|June 19, 2019
Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomasMaría García-Álvarez, Sara Alonso-Álvarez, Isabel Prieto-Conde, et al.
British Journal of Haematology|May 29, 2024
Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual diseaseMiguel Alcoceba, James P Stewart, María García-Álvarez, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 21, 2023
[<sup>18</sup>F]DCFPyL PET/CT versus [<sup>18</sup>F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative studyDaniela-Elena Oprea-Lager, Eric Gontier, Lina García-Cañamaque, et al.
Cancers|January 8, 2025
The Value of Bone Marrow Assessment by FDG PET/CT, Biopsy and Aspirate in the Upfront Evaluation of Mantle Cell Lymphoma: A Nationwide Cohort StudyIsabel Ródenas Quiñonero, Javier Marco-Ayala, Tzu-Hua Chen-Liang, et al.
Blood Advances|November 27, 2024
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myelomaInés Zugasti, Marta Tormo-Ratera, Aina Oliver-Caldés, et al.
Cancer Medicine|November 14, 2022
Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort studyIsabel Ródenas-Quiñonero, Tzu Chen-Liang, Taida Martín-Santos, et al.
Cancer Medicine|September 30, 2017
Bone marrow biopsy superiority over PET/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphomaTzu-Hua Chen-Liang, Taida Martín-Santos, Andrés Jerez, et al.
Pageof 2